Fig. 4.
The proportion of myositis patients within each autoantibody defined subgroup who received treatment with intravenous cyclophosphamide (dark grey) and/or a biologic drug (light grey) is shown.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.